Live Breaking News & Updates on Oxford Vaccines|Page 3
Stay updated with breaking news from Oxford vaccines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Synopsis The research, posted as a pre-print and yet to be peer-reviewed, estimated the effect of both the COVID-19 vaccines on laboratory confirmed symptomatic disease in individuals aged 70 years or older in England. AP The data also shows symptomatic infections in over 70s decreased from around three weeks after one dose of both vaccines. The Pfizer and Oxford-AstraZeneca vaccines for COVID-19 are highly effective in reducing severe coronavirus infection among people aged 70 years and above, according to a study. The research, posted as a pre-print and yet to be peer-reviewed, estimated the effect of both the COVID-19 vaccines on laboratory confirmed symptomatic disease in individuals aged 70 years or older in England. ....
The data revealed that the protection from Covid infection 35 days after taking the first dose is slightly better for the AstreZeneca vaccine than for P. ....